"Meridian Clinical Research studies the safety and efficacy of new treatments. When people like you participate in clinical trials, we can uncover better ways to treat conditions that may affect you and your loved ones. Meridian's Omaha site conducts research for a broad range of investigational treatments. Studies at this site explore vaccines and medicines developed to treat migraines, acne, depression, high cholesterol, and other conditions."

During the past decade, Meridian Clinical Research, LLC conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 55 clinical trials were completed, i.e. on average, 76.4% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 29 clinical trials were completed. i.e. 78.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meridian Clinical Research, LLC" #1 sponsor was "Pfizer" with 26 trials, followed by "MedImmune LLC" with 9 trials sponsored, "ModernaTX, Inc." with 8 trials sponsored, "Protein Sciences Corporation" with 6 trials sponsored and "Novartis" with 6 trials sponsored. Other sponsors include 72 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meridian Clinical Research, LLC" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 5 trials as a collaborator, "Pfizer" with 5 trials as a collaborator, "Department of Health and Human Services" with 4 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator and "GlaxoSmithKline" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Meridian Clinical Research, LLC" are "Influenza" (18 trials), "SARS-CoV-2 Infection" (7 trials), "COVID-19" (6 trials), "Pneumococcal Disease" (5 trials) and "Healthy" (4 trials). Many other conditions were trialed in "Meridian Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Meridian Clinical Research, LLC" are "Biological" (81 trials), "Drug" (52 trials), "Other" (20 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "Saline" (5 trials), "BNT162b2" (4 trials), "20vPnC" (3 trials) and "Clostridium difficile vaccine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Meridian Clinical Research, LLC" are 126 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Meridian Clinical Research, LLC". undefined are not yet recruiting, 5 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 107 completed trials in Meridian Clinical Research, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Meridian Clinical Research, LLC, 17 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 3 trials that are defined as “Not Applicable".

Meridian Clinical Research, LLC has several departments that took part in Clinical trials: "Meridian Clinical Research" - 4 trials, "Meridian Clinical Research, LLC" - 5 trials, "Meridian Clinical Research - Urology" - 2 trials